Mangoceuticals (MGRX) Current Assets (2022 - 2026)

Mangoceuticals has disclosed Current Assets across 5 years of filings, most recently posting $245687.0 for Q2 2026.

• In Q2 2026, Current Assets rose 108.28% year-over-year to $245687.0; the TTM figure through Jun 2026 stood at $245687.0 (up 108.28% YoY), while the FY2025 annual figure was $1.5 million, up 1947.01% from the prior year.
• Current Assets came in at $245687.0 for Q2 2026 at Mangoceuticals, up from $212472.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $3.8 million in Q1 2023 to a low of $75595.0 in Q4 2024.
• Average Current Assets over 5 years is $893627.8, with a median of $517561.0 recorded in 2024.
• Year-over-year, Current Assets sank 97.65% in 2024 and surged 1947.01% in 2025.
• Over 5 years, Current Assets stood at $694605.0 in 2022, then rose by 20.27% to $835402.0 in 2023, then plunged by 90.95% to $75595.0 in 2024, then surged by 1947.01% to $1.5 million in 2025, then tumbled by 84.12% to $245687.0 in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $245687.0 in Q2 2026, $212472.0 in Q1 2026, and $1.5 million in Q4 2025.